Pig Liver Xenografts Show Promise as Bridge Therapy in Groundbreaking Multiomics Study
A deep multiomics analysis of pig-to-human liver cross-circulation reveals how the immune system attacks xenografts and causes platelet collapse.
Summary
Researchers at NYU Langone and partner institutions performed detailed molecular profiling of a revolutionary procedure: connecting gene-edited pig livers to brain-dead human donors to study cross-species liver support. Using proteomics, lipidomics, metabolomics, and spatial transcriptomics across 64 blood samples and 28 liver biopsies, they mapped exactly how the human immune system attacks the pig liver over time. Human inflammatory macrophages and neutrophils progressively invaded the xenografts while pig immune cells disappeared. The pig liver performed key functions — clearing bilirubin, synthesizing proteins, and supporting energy metabolism — but also triggered severe platelet loss. The findings pinpoint molecular targets for improving pig liver biocompatibility, a critical step toward making this technology viable for patients with acute liver failure awaiting transplant.
Detailed Summary
Acute liver failure kills thousands of patients annually who cannot survive the wait for a donor organ. Gene-edited pig livers, used as temporary external support devices, could serve as a life-saving bridge — but the human immune system mounts a fierce attack on foreign tissue. Understanding that attack in molecular detail is essential to making xenograft therapy clinically viable.
Researchers performed extracorporeal liver cross-circulation (ELC) in five procedures across four brain-dead human decedents, circulating the human blood supply through externally connected, gene-edited pig livers. To map the resulting host-xenograft interactions, the team conducted longitudinal proteomic, lipidomic, and metabolomic analysis of 64 blood samples, combined with spatial transcriptomics and histology of 25 pig liver and 3 human liver biopsies — one of the most comprehensive multiomics profiles of xenotransplantation to date.
Spatial transcriptomics revealed a dramatic immune invasion: human inflammatory macrophages and neutrophils progressively infiltrated pig liver tissue as native porcine Kupffer cells and T cells disappeared. Notably, human complement pathways were suppressed while porcine complement was paradoxically elevated. Pig acute-phase proteins and coagulation factors surged over time. Severe thrombocytopenia — dangerous platelet loss — was a consistent complication, traced to human platelets accumulating around activated pig endothelial cells expressing rising levels of von Willebrand factor, alongside clusters of macrophages, neutrophils, and hepatocytes.
Despite the immune assault, the pig livers delivered meaningful hepatic support: bilirubin was cleared, apolipoproteins were synthesized, and energy metabolism was maintained, though circulating lipid levels remained depressed under anhepatic conditions.
These findings define specific cellular and molecular targets — including complement dysregulation, platelet-endothelial interactions, and von Willebrand factor expression — that future genetic engineering of donor pigs must address to make ELC therapy safe for clinical use.
Key Findings
- Human macrophages and neutrophils progressively invaded pig liver xenografts as native porcine immune cells were displaced.
- Severe platelet loss was linked to human platelets clustering around pig endothelial cells with rising von Willebrand factor expression.
- Human complement was suppressed while porcine complement rose unexpectedly, creating a dysregulated cross-species immune environment.
- Pig livers provided real hepatic function: bilirubin clearance, apolipoprotein synthesis, and energy metabolism support were all detected.
- Multiomics profiling identified specific molecular targets to improve xenograft biocompatibility for future clinical translation.
Methodology
Five extracorporeal liver cross-circulation procedures were performed in four brain-dead human decedents using gene-edited pig liver xenografts. Longitudinal multiomics profiling included proteomics, lipidomics, and metabolomics of 64 blood samples, plus spatial transcriptomics and histology of 25 porcine and 3 human liver biopsies. The study is observational and conducted under controlled research conditions in decedents rather than living patients.
Study Limitations
The summary is based on the abstract only, as the full paper is not open access. The study was performed in brain-dead human decedents, not living patients, limiting direct clinical extrapolation. The sample size of five procedures across four individuals is very small, and findings may not fully reflect immune dynamics in a living physiological context.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: